Quest Diagnostics
DGX
535 hedge funds and large institutions have $9.43B invested in Quest Diagnostics in 2015 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 170 increasing their positions, 204 reducing their positions, and 61 closing their positions.
140% more call options, than puts
Call options by funds: $66.2M | Put options by funds: $27.5M
100% more funds holding in top 10
Funds holding in top 10: 5 → 10 (+5)
16% more capital invested
Capital invested by funds: $8.13B → $9.43B (+$1.3B)
0.34% more ownership
Funds ownership: 92.24% → 92.58% (+0.34%)
0% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 61
1% less funds holding
Funds holding: 540 → 535 (-5)
17% less repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 204
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
+$231M |
| 2 |
Bessemer Group
Woodbridge,
New Jersey
|
+$116M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$79.9M |
| 4 |
Goldman Sachs
New York
|
+$45.6M |
| 5 |
HM
HealthCor Management
New York
|
+$35.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$218M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$82.5M |
| 3 |
DSA
Davis Selected Advisers
Tucson,
Arizona
|
-$41.2M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$33.4M |
| 5 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$23.6M |
DGX Hedge Fund Activity: Q4 2015 in Review
535 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q4 2015, worth a combined $9.43B — up 16% from $8.13B a quarter earlier.
Fund positioning in DGX was balanced in Q4 2015: 61 funds opened new positions, 61 closed out, 170 added to existing stakes and 204 trimmed.
The largest buyer was Allianz Asset Management, adding an estimated $231M. The largest seller was Capital International Investors, cutting an estimated $218M.
- 535 institutional investors held Quest Diagnostics (DGX) as of Q4 2015, down from 540 in Q3 2015.
- Funds reported $9.43B of Quest Diagnostics stock for Q4 2015, up 16% quarter-over-quarter.
- 61 funds opened new Quest Diagnostics positions in Q4 2015 and 61 closed out, a net change of 0 holders.
- The largest Quest Diagnostics buyer in Q4 2015 was Allianz Asset Management, an estimated $231M added.
- The largest Quest Diagnostics seller in Q4 2015 was Capital International Investors, an estimated $218M sold.
Based on aggregated 13F filings for Q4 2015.